カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のうつ病治療装置市場2022年：経頭蓋直流刺激（tDCS）、経頭蓋交流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他

◆英語タイトル：Global Depression Treatment Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY7780 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：102 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

うつ病治療装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のうつ病治療装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

うつ病治療装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・経頭蓋直流刺激（tDCS）、経頭蓋交流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他

用途別セグメントは次のように区分されます。
・病院、クリニック、その他

世界のうつ病治療装置市場の主要な市場プレーヤーは以下のとおりです。
・Flow Neuroscience AB、Ginger、Electromedical Products International, Inc.、Neuronetics、Alpha-Stim、Fisher Wallace Laboratories、Neurolief、INNOVATIVE NEUROLOGICAL Devices LLC、Magnus Medical、Flow Neuroscience、BrainsWay、Caputron Medical、NeuroStar、The Magstim Company Limited

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、うつ病治療装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なうつ病治療装置メーカーの企業概要、2019年～2022年までのうつ病治療装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なうつ病治療装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別うつ病治療装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのうつ病治療装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのうつ病治療装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびうつ病治療装置の産業チェーンを掲載しています。
・第13、14、15章では、うつ病治療装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Flow Neuroscience AB、Ginger、Electromedical Products International, Inc.、Neuronetics、Alpha-Stim、Fisher Wallace Laboratories、Neurolief、INNOVATIVE NEUROLOGICAL Devices LLC、Magnus Medical、Flow Neuroscience、BrainsWay、Caputron Medical、NeuroStar、The Magstim Company Limited
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：経頭蓋直流刺激（tDCS）、経頭蓋交流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他
・用途別分析2017年-2028年：病院、クリニック、その他
・うつ病治療装置の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・うつ病治療装置のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・うつ病治療装置のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・うつ病治療装置の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・うつ病治療装置の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Depression Treatment Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Depression Treatment Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Depression Treatment Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Transcranial Direct Current Stimulation (tDCS) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Depression Treatment Device include Flow Neuroscience AB, Ginger, Electromedical Products International, Inc., Neuronetics, and Alpha-Stim, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Depression Treatment Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Transcranial Direct Current Stimulation (tDCS)
Transcranial Alternating Current Stimulation (tACS)
Transcranial Pulsed Current Stimulation (tPCS)
Transcranial Random Noise Stimulation (tRNS)
Electroconvulsive therapy (ECT)
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Depression Treatment Device market are listed below:
Flow Neuroscience AB
Ginger
Electromedical Products International, Inc.
Neuronetics
Alpha-Stim
Fisher Wallace Laboratories
Neurolief
INNOVATIVE NEUROLOGICAL Devices LLC
Magnus Medical
Flow Neuroscience
BrainsWay
Caputron Medical
NeuroStar
The Magstim Company Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Depression Treatment Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Depression Treatment Device, with price, sales, revenue and global market share of Depression Treatment Device from 2019 to 2022.
Chapter 3, the Depression Treatment Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Depression Treatment Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Depression Treatment Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Depression Treatment Device.
Chapter 13, 14, and 15, to describe Depression Treatment Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Depression Treatment Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Depression Treatment Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Transcranial Direct Current Stimulation (tDCS)
1.2.3 Transcranial Alternating Current Stimulation (tACS)
1.2.4 Transcranial Pulsed Current Stimulation (tPCS)
1.2.5 Transcranial Random Noise Stimulation (tRNS)
1.2.6 Electroconvulsive therapy (ECT)
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Depression Treatment Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Depression Treatment Device Market Size & Forecast
1.4.1 Global Depression Treatment Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Depression Treatment Device Sales in Volume (2017-2028)
1.4.3 Global Depression Treatment Device Price (2017-2028)
1.5 Global Depression Treatment Device Production Capacity Analysis
1.5.1 Global Depression Treatment Device Total Production Capacity (2017-2028)
1.5.2 Global Depression Treatment Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Depression Treatment Device Market Drivers
1.6.2 Depression Treatment Device Market Restraints
1.6.3 Depression Treatment Device Trends Analysis
2 Manufacturers Profiles
2.1 Flow Neuroscience AB
2.1.1 Flow Neuroscience AB Details
2.1.2 Flow Neuroscience AB Major Business
2.1.3 Flow Neuroscience AB Depression Treatment Device Product and Services
2.1.4 Flow Neuroscience AB Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ginger
2.2.1 Ginger Details
2.2.2 Ginger Major Business
2.2.3 Ginger Depression Treatment Device Product and Services
2.2.4 Ginger Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Electromedical Products International, Inc.
2.3.1 Electromedical Products International, Inc. Details
2.3.2 Electromedical Products International, Inc. Major Business
2.3.3 Electromedical Products International, Inc. Depression Treatment Device Product and Services
2.3.4 Electromedical Products International, Inc. Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Neuronetics
2.4.1 Neuronetics Details
2.4.2 Neuronetics Major Business
2.4.3 Neuronetics Depression Treatment Device Product and Services
2.4.4 Neuronetics Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Alpha-Stim
2.5.1 Alpha-Stim Details
2.5.2 Alpha-Stim Major Business
2.5.3 Alpha-Stim Depression Treatment Device Product and Services
2.5.4 Alpha-Stim Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Fisher Wallace Laboratories
2.6.1 Fisher Wallace Laboratories Details
2.6.2 Fisher Wallace Laboratories Major Business
2.6.3 Fisher Wallace Laboratories Depression Treatment Device Product and Services
2.6.4 Fisher Wallace Laboratories Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Neurolief
2.7.1 Neurolief Details
2.7.2 Neurolief Major Business
2.7.3 Neurolief Depression Treatment Device Product and Services
2.7.4 Neurolief Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 INNOVATIVE NEUROLOGICAL Devices LLC
2.8.1 INNOVATIVE NEUROLOGICAL Devices LLC Details
2.8.2 INNOVATIVE NEUROLOGICAL Devices LLC Major Business
2.8.3 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product and Services
2.8.4 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Magnus Medical
2.9.1 Magnus Medical Details
2.9.2 Magnus Medical Major Business
2.9.3 Magnus Medical Depression Treatment Device Product and Services
2.9.4 Magnus Medical Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Flow Neuroscience
2.10.1 Flow Neuroscience Details
2.10.2 Flow Neuroscience Major Business
2.10.3 Flow Neuroscience Depression Treatment Device Product and Services
2.10.4 Flow Neuroscience Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 BrainsWay
2.11.1 BrainsWay Details
2.11.2 BrainsWay Major Business
2.11.3 BrainsWay Depression Treatment Device Product and Services
2.11.4 BrainsWay Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Caputron Medical
2.12.1 Caputron Medical Details
2.12.2 Caputron Medical Major Business
2.12.3 Caputron Medical Depression Treatment Device Product and Services
2.12.4 Caputron Medical Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 NeuroStar
2.13.1 NeuroStar Details
2.13.2 NeuroStar Major Business
2.13.3 NeuroStar Depression Treatment Device Product and Services
2.13.4 NeuroStar Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 The Magstim Company Limited
2.14.1 The Magstim Company Limited Details
2.14.2 The Magstim Company Limited Major Business
2.14.3 The Magstim Company Limited Depression Treatment Device Product and Services
2.14.4 The Magstim Company Limited Depression Treatment Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Depression Treatment Device Breakdown Data by Manufacturer
3.1 Global Depression Treatment Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Depression Treatment Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Depression Treatment Device
3.4 Market Concentration Rate
3.4.1 Top 3 Depression Treatment Device Manufacturer Market Share in 2021
3.4.2 Top 6 Depression Treatment Device Manufacturer Market Share in 2021
3.5 Global Depression Treatment Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Depression Treatment Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Depression Treatment Device Market Size by Region
4.1.1 Global Depression Treatment Device Sales in Volume by Region (2017-2028)
4.1.2 Global Depression Treatment Device Revenue by Region (2017-2028)
4.2 North America Depression Treatment Device Revenue (2017-2028)
4.3 Europe Depression Treatment Device Revenue (2017-2028)
4.4 Asia-Pacific Depression Treatment Device Revenue (2017-2028)
4.5 South America Depression Treatment Device Revenue (2017-2028)
4.6 Middle East and Africa Depression Treatment Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Depression Treatment Device Sales in Volume by Type (2017-2028)
5.2 Global Depression Treatment Device Revenue by Type (2017-2028)
5.3 Global Depression Treatment Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Depression Treatment Device Sales in Volume by Application (2017-2028)
6.2 Global Depression Treatment Device Revenue by Application (2017-2028)
6.3 Global Depression Treatment Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Depression Treatment Device Sales by Type (2017-2028)
7.2 North America Depression Treatment Device Sales by Application (2017-2028)
7.3 North America Depression Treatment Device Market Size by Country
7.3.1 North America Depression Treatment Device Sales in Volume by Country (2017-2028)
7.3.2 North America Depression Treatment Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Depression Treatment Device Sales by Type (2017-2028)
8.2 Europe Depression Treatment Device Sales by Application (2017-2028)
8.3 Europe Depression Treatment Device Market Size by Country
8.3.1 Europe Depression Treatment Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Depression Treatment Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Depression Treatment Device Sales by Type (2017-2028)
9.2 Asia-Pacific Depression Treatment Device Sales by Application (2017-2028)
9.3 Asia-Pacific Depression Treatment Device Market Size by Region
9.3.1 Asia-Pacific Depression Treatment Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Depression Treatment Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Depression Treatment Device Sales by Type (2017-2028)
10.2 South America Depression Treatment Device Sales by Application (2017-2028)
10.3 South America Depression Treatment Device Market Size by Country
10.3.1 South America Depression Treatment Device Sales in Volume by Country (2017-2028)
10.3.2 South America Depression Treatment Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Depression Treatment Device Sales by Type (2017-2028)
11.2 Middle East & Africa Depression Treatment Device Sales by Application (2017-2028)
11.3 Middle East & Africa Depression Treatment Device Market Size by Country
11.3.1 Middle East & Africa Depression Treatment Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Depression Treatment Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Depression Treatment Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Depression Treatment Device
12.3 Depression Treatment Device Production Process
12.4 Depression Treatment Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Depression Treatment Device Typical Distributors
13.3 Depression Treatment Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Depression Treatment Device Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Depression Treatment Device Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Flow Neuroscience AB Basic Information, Manufacturing Base and Competitors
Table 4. Flow Neuroscience AB Major Business
Table 5. Flow Neuroscience AB Depression Treatment Device Product and Services
Table 6. Flow Neuroscience AB Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Ginger Basic Information, Manufacturing Base and Competitors
Table 8. Ginger Major Business
Table 9. Ginger Depression Treatment Device Product and Services
Table 10. Ginger Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Electromedical Products International, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Electromedical Products International, Inc. Major Business
Table 13. Electromedical Products International, Inc. Depression Treatment Device Product and Services
Table 14. Electromedical Products International, Inc. Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Neuronetics Basic Information, Manufacturing Base and Competitors
Table 16. Neuronetics Major Business
Table 17. Neuronetics Depression Treatment Device Product and Services
Table 18. Neuronetics Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Alpha-Stim Basic Information, Manufacturing Base and Competitors
Table 20. Alpha-Stim Major Business
Table 21. Alpha-Stim Depression Treatment Device Product and Services
Table 22. Alpha-Stim Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Fisher Wallace Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Fisher Wallace Laboratories Major Business
Table 25. Fisher Wallace Laboratories Depression Treatment Device Product and Services
Table 26. Fisher Wallace Laboratories Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Neurolief Basic Information, Manufacturing Base and Competitors
Table 28. Neurolief Major Business
Table 29. Neurolief Depression Treatment Device Product and Services
Table 30. Neurolief Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. INNOVATIVE NEUROLOGICAL Devices LLC Basic Information, Manufacturing Base and Competitors
Table 32. INNOVATIVE NEUROLOGICAL Devices LLC Major Business
Table 33. INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product and Services
Table 34. INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Magnus Medical Basic Information, Manufacturing Base and Competitors
Table 36. Magnus Medical Major Business
Table 37. Magnus Medical Depression Treatment Device Product and Services
Table 38. Magnus Medical Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Flow Neuroscience Basic Information, Manufacturing Base and Competitors
Table 40. Flow Neuroscience Major Business
Table 41. Flow Neuroscience Depression Treatment Device Product and Services
Table 42. Flow Neuroscience Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. BrainsWay Basic Information, Manufacturing Base and Competitors
Table 44. BrainsWay Major Business
Table 45. BrainsWay Depression Treatment Device Product and Services
Table 46. BrainsWay Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Caputron Medical Basic Information, Manufacturing Base and Competitors
Table 48. Caputron Medical Major Business
Table 49. Caputron Medical Depression Treatment Device Product and Services
Table 50. Caputron Medical Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. NeuroStar Basic Information, Manufacturing Base and Competitors
Table 52. NeuroStar Major Business
Table 53. NeuroStar Depression Treatment Device Product and Services
Table 54. NeuroStar Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. The Magstim Company Limited Basic Information, Manufacturing Base and Competitors
Table 56. The Magstim Company Limited Major Business
Table 57. The Magstim Company Limited Depression Treatment Device Product and Services
Table 58. The Magstim Company Limited Depression Treatment Device Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Depression Treatment Device Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Depression Treatment Device Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Depression Treatment Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Depression Treatment Device Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Depression Treatment Device Production Site of Key Manufacturer
Table 64. Depression Treatment Device New Entrant and Capacity Expansion Plans
Table 65. Depression Treatment Device Mergers & Acquisitions in the Past Five Years
Table 66. Global Depression Treatment Device Sales by Region (2017-2022) & (K Units)
Table 67. Global Depression Treatment Device Sales by Region (2023-2028) & (K Units)
Table 68. Global Depression Treatment Device Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Depression Treatment Device Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Depression Treatment Device Sales by Type (2017-2022) & (K Units)
Table 71. Global Depression Treatment Device Sales by Type (2023-2028) & (K Units)
Table 72. Global Depression Treatment Device Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Depression Treatment Device Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Depression Treatment Device Price by Type (2017-2022) & (US$/Unit)
Table 75. Global Depression Treatment Device Price by Type (2023-2028) & (US$/Unit)
Table 76. Global Depression Treatment Device Sales by Application (2017-2022) & (K Units)
Table 77. Global Depression Treatment Device Sales by Application (2023-2028) & (K Units)
Table 78. Global Depression Treatment Device Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Depression Treatment Device Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Depression Treatment Device Price by Application (2017-2022) & (US$/Unit)
Table 81. Global Depression Treatment Device Price by Application (2023-2028) & (US$/Unit)
Table 82. North America Depression Treatment Device Sales by Country (2017-2022) & (K Units)
Table 83. North America Depression Treatment Device Sales by Country (2023-2028) & (K Units)
Table 84. North America Depression Treatment Device Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Depression Treatment Device Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Depression Treatment Device Sales by Type (2017-2022) & (K Units)
Table 87. North America Depression Treatment Device Sales by Type (2023-2028) & (K Units)
Table 88. North America Depression Treatment Device Sales by Application (2017-2022) & (K Units)
Table 89. North America Depression Treatment Device Sales by Application (2023-2028) & (K Units)
Table 90. Europe Depression Treatment Device Sales by Country (2017-2022) & (K Units)
Table 91. Europe Depression Treatment Device Sales by Country (2023-2028) & (K Units)
Table 92. Europe Depression Treatment Device Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Depression Treatment Device Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Depression Treatment Device Sales by Type (2017-2022) & (K Units)
Table 95. Europe Depression Treatment Device Sales by Type (2023-2028) & (K Units)
Table 96. Europe Depression Treatment Device Sales by Application (2017-2022) & (K Units)
Table 97. Europe Depression Treatment Device Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Depression Treatment Device Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Depression Treatment Device Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Depression Treatment Device Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Depression Treatment Device Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Depression Treatment Device Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Depression Treatment Device Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Depression Treatment Device Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Depression Treatment Device Sales by Application (2023-2028) & (K Units)
Table 106. South America Depression Treatment Device Sales by Country (2017-2022) & (K Units)
Table 107. South America Depression Treatment Device Sales by Country (2023-2028) & (K Units)
Table 108. South America Depression Treatment Device Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Depression Treatment Device Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Depression Treatment Device Sales by Type (2017-2022) & (K Units)
Table 111. South America Depression Treatment Device Sales by Type (2023-2028) & (K Units)
Table 112. South America Depression Treatment Device Sales by Application (2017-2022) & (K Units)
Table 113. South America Depression Treatment Device Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Depression Treatment Device Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Depression Treatment Device Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Depression Treatment Device Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Depression Treatment Device Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Depression Treatment Device Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Depression Treatment Device Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Depression Treatment Device Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Depression Treatment Device Sales by Application (2023-2028) & (K Units)
Table 122. Depression Treatment Device Raw Material
Table 123. Key Manufacturers of Depression Treatment Device Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Depression Treatment Device Typical Distributors
Table 127. Depression Treatment Device Typical Customers
List of Figures
Figure 1. Depression Treatment Device Picture
Figure 2. Global Depression Treatment Device Revenue Market Share by Type in 2021
Figure 3. Transcranial Direct Current Stimulation (tDCS)
Figure 4. Transcranial Alternating Current Stimulation (tACS)
Figure 5. Transcranial Pulsed Current Stimulation (tPCS)
Figure 6. Transcranial Random Noise Stimulation (tRNS)
Figure 7. Electroconvulsive therapy (ECT)
Figure 8. Others
Figure 9. Global Depression Treatment Device Revenue Market Share by Application in 2021
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Depression Treatment Device Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Depression Treatment Device Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Depression Treatment Device Sales (2017-2028) & (K Units)
Figure 16. Global Depression Treatment Device Price (2017-2028) & (US$/Unit)
Figure 17. Global Depression Treatment Device Production Capacity (2017-2028) & (K Units)
Figure 18. Global Depression Treatment Device Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Depression Treatment Device Market Drivers
Figure 20. Depression Treatment Device Market Restraints
Figure 21. Depression Treatment Device Market Trends
Figure 22. Global Depression Treatment Device Sales Market Share by Manufacturer in 2021
Figure 23. Global Depression Treatment Device Revenue Market Share by Manufacturer in 2021
Figure 24. Depression Treatment Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Depression Treatment Device Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Depression Treatment Device Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Depression Treatment Device Sales Market Share by Region (2017-2028)
Figure 28. Global Depression Treatment Device Revenue Market Share by Region (2017-2028)
Figure 29. North America Depression Treatment Device Revenue (2017-2028) & (USD Million)
Figure 30. Europe Depression Treatment Device Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Depression Treatment Device Revenue (2017-2028) & (USD Million)
Figure 32. South America Depression Treatment Device Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Depression Treatment Device Revenue (2017-2028) & (USD Million)
Figure 34. Global Depression Treatment Device Sales Market Share by Type (2017-2028)
Figure 35. Global Depression Treatment Device Revenue Market Share by Type (2017-2028)
Figure 36. Global Depression Treatment Device Price by Type (2017-2028) & (US$/Unit)
Figure 37. Global Depression Treatment Device Sales Market Share by Application (2017-2028)
Figure 38. Global Depression Treatment Device Revenue Market Share by Application (2017-2028)
Figure 39. Global Depression Treatment Device Price by Application (2017-2028) & (US$/Unit)
Figure 40. North America Depression Treatment Device Sales Market Share by Type (2017-2028)
Figure 41. North America Depression Treatment Device Sales Market Share by Application (2017-2028)
Figure 42. North America Depression Treatment Device Sales Market Share by Country (2017-2028)
Figure 43. North America Depression Treatment Device Revenue Market Share by Country (2017-2028)
Figure 44. United States Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Depression Treatment Device Sales Market Share by Type (2017-2028)
Figure 48. Europe Depression Treatment Device Sales Market Share by Application (2017-2028)
Figure 49. Europe Depression Treatment Device Sales Market Share by Country (2017-2028)
Figure 50. Europe Depression Treatment Device Revenue Market Share by Country (2017-2028)
Figure 51. Germany Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Depression Treatment Device Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Depression Treatment Device Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Depression Treatment Device Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Depression Treatment Device Revenue Market Share by Region (2017-2028)
Figure 60. China Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Depression Treatment Device Sales Market Share by Type (2017-2028)
Figure 67. South America Depression Treatment Device Sales Market Share by Application (2017-2028)
Figure 68. South America Depression Treatment Device Sales Market Share by Country (2017-2028)
Figure 69. South America Depression Treatment Device Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Depression Treatment Device Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Depression Treatment Device Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Depression Treatment Device Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Depression Treatment Device Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Depression Treatment Device Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Depression Treatment Device in 2021
Figure 81. Manufacturing Process Analysis of Depression Treatment Device
Figure 82. Depression Treatment Device Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のうつ病治療装置市場2022年：経頭蓋直流刺激（tDCS）、経頭蓋交流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他(Global Depression Treatment Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のうつ病治療装置市場2022年：経頭蓋直流刺激（tDCS）、経頭蓋交流刺激（tACS）、経頭蓋パルス電流刺激（tPCS）、経頭蓋ランダムノイズ刺激（tRNS）、電気けいれん療法（ECT）、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp